Penserra Capital Management LLC Acquires 2,776 Shares of CME Group Inc. (NASDAQ:CME)

Penserra Capital Management LLC increased its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 108.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,343 shares of the financial services provider's stock after buying an additional 2,776 shares during the quarter. Penserra Capital Management LLC's holdings in CME Group were worth $1,416,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of CME. Wayfinding Financial LLC acquired a new position in shares of CME Group in the 1st quarter worth approximately $25,000. New Age Alpha Advisors LLC increased its holdings in shares of CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after purchasing an additional 43 shares in the last quarter. Golden State Wealth Management LLC boosted its stake in CME Group by 612.5% in the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after acquiring an additional 98 shares during the last quarter. Alpine Bank Wealth Management bought a new position in CME Group in the first quarter valued at approximately $32,000. Finally, Knuff & Co LLC acquired a new position in CME Group in the fourth quarter valued at about $33,000. 87.75% of the stock is currently owned by institutional investors.

CME Group Stock Down 0.0%

Shares of CME traded down $0.11 during trading hours on Friday, reaching $275.08. 1,531,570 shares of the stock traded hands, compared to its average volume of 2,181,193. The company has a market cap of $99.13 billion, a price-to-earnings ratio of 27.67, a PEG ratio of 4.44 and a beta of 0.44. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 52 week low of $193.25 and a 52 week high of $290.79. The stock has a fifty day simple moving average of $276.58 and a 200 day simple moving average of $259.37.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.61 by $0.19. The firm had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The company's revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the company earned $2.50 earnings per share. On average, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were paid a $1.25 dividend. The ex-dividend date was Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.82%. CME Group's dividend payout ratio is presently 50.30%.

Insider Buying and Selling

In related news, Director William R. Shepard acquired 256 shares of the firm's stock in a transaction on Wednesday, June 25th. The stock was acquired at an average cost of $270.53 per share, for a total transaction of $69,255.68. Following the acquisition, the director owned 258,196 shares of the company's stock, valued at $69,849,763.88. This trade represents a 0.10% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Daniel G. Kaye sold 500 shares of the firm's stock in a transaction that occurred on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total value of $141,210.00. Following the transaction, the director directly owned 3,668 shares of the company's stock, valued at approximately $1,035,916.56. This trade represents a 12.00% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 13,400 shares of company stock worth $3,680,610 in the last ninety days. 0.30% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Bank of America boosted their price objective on shares of CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a research report on Wednesday, April 2nd. Oppenheimer upped their price target on shares of CME Group from $282.00 to $300.00 and gave the company an "outperform" rating in a research note on Wednesday, June 4th. Wall Street Zen raised shares of CME Group from a "sell" rating to a "hold" rating in a report on Saturday, July 5th. UBS Group increased their price objective on shares of CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a research note on Friday, April 25th. Finally, Piper Sandler increased their price objective on shares of CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a research note on Tuesday, April 8th. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $260.93.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.